Compound or practice · Supplement

Chaga

An antioxidant-rich fungus with essentially no human trials — and a real oxalate/kidney caution.

Overall grade
Grade D
Last revised
1
graded outcome
0
references listed

A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.

1 at grade D — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Immunity / antioxidant (humans)Evidence grade D

    No trials

    Unclearlow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Immunity / antioxidant (humans) (grade D).

The evidence in words

What it is

Chaga (Inonotus obliquus) is a birch fungus marketed for immunity and antioxidant support.

How it works

High in antioxidants and beta-glucans; human effects unstudied.

What the evidence shows

Human clinical evidence is essentially absent (mostly cell and animal work). Chaga is also very high in oxalates, with case reports of kidney injury at high intake.

How to use it

Not recommended in high doses given the oxalate risk.

Safety & interactions

Oxalate load — kidney-stone/injury risk; caution with anticoagulants and diabetes drugs.

Bottom line

No human evidence and a genuine kidney-oxalate risk. Not worth it.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

n/a
Avoid high doses (oxalates).

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own.

Last revised . A grade is this entry's reading of the evidence, not medical advice.